将血清生物标志物与PAGE B评分结合,改善了慢性乙型肝炎患者肝细胞癌的风险分层

Michael Stec1, Mark Anderson2, Mary A Rodgers2

  • 1Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA. michael.e.stec@gmail.com.

Scientific reports
|August 26, 2025
PubMed
概括

结合LG2m,AFP,PIVKA-II和PAGE-B的新风险分层方法显示了早期肝细胞癌 (HCC) 检测的高灵敏度. 这种方法有助于识别患者的治愈治疗而不是息治疗.